title: Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
authors.forename: Laura
authors.initials: L
authors.lastname: Obici
authors.forename: Antonella
authors.initials: A
authors.lastname: Meini
authors.forename: Marco
authors.initials: M
authors.lastname: Cattalini
authors.forename: Silvana
authors.initials: S
authors.lastname: Chicca
authors.forename: Marco
authors.initials: M
authors.lastname: Galliani
authors.forename: Simona
authors.initials: S
authors.lastname: Donadei
authors.forename: Alessandro
authors.initials: A
authors.lastname: Plebani
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Merlini
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D010505:Familial Mediterranean Fever / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D018124:Receptors, Tumor Necrosis Factor